Drug development for sickle-cell disease, largely neglected for decades, is becoming a crowded field: two papers published on Saturday in the New England Journal of Medicine give promising results from a study of experimental therapies, including Crisper gene editing for the disease. In addition, Beam Therapeutics Inc. The American Society …
Read More »Covid-19 rejection poses another challenge to health-care workers
Dr .. Michelle Schultz Bayes, shifts overnight at St. Lucas Health System Hospitals near Idaho, treating several hundred critically ill Covid-19 patients filling hospital beds in her state during the most severe epidemic period so far. She, like many other health care workers, faces another challenge in light of the …
Read More »Amazon’s fears gripped as internet retail giant shakes up pharmacy business
Amazon.com has been one of the most innovative and disorganized companies of this century, with incredible success in areas beyond historically considered its core business (book sales). Thus every ad or speculation Amazon AMZN, -0.96% Whoever enters a particular industry sends the shares of that industry into the tailspin. Investors …
Read More »Covid-19 vaccine test from AstraZeneca, Ox Xford U.S. Can resume in
Federal health regulators have ruled out a leading Covid-19 vaccine candidate from AstraZeneca AZN in the U.S. Allowed the study to resume. 0.08% According to a person familiar with the matter and content reviewed by Wall Street Journal, PLC and Oxford University. U.S. The Food and Drug Administration wrapped up …
Read More »Walmart files pre-emotional lawsuit against federal government in opioid case
Walmart Inc. WMT -0.59% The Department of Justice sued the federal government in an attempt to strike a pre-emptive blow against what it said was an opioid-related civil lawsuit. The retail company said in a lawsuit filed Thursday that the Department of Justice and the Drug Enforcement Administration are seeking …
Read More »